SYNBIOTIC SE |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.44 EUR | -2.11% |
|
-3.88% | +148.83% |
| 05-14 | WDH/Survey: Seven percent of adults have bought cannabis seeds | DP |
| 05-09 | Medical Cannabis Group SynBiotic Buys Local Peer Weeco Pharma | MT |
| Sales 2021 | 9.06 8.48 717.49 | Sales 2022 | 8.17 7.64 646.39 | Capitalization | 37.92M 35.46M 3B |
|---|---|---|---|---|---|
| Net income 2021 | -12M -11.22M -950M | Net income 2022 | -24M -22.44M -1.9B | EV / Sales 2021 | 10,783,962 x |
| Net Debt 2021 | 215K 201K 17M | Net Debt 2022 | 3.17M 2.96M 251M | EV / Sales 2022 | 5,031,340 x |
| P/E ratio 2021 |
-7.04
x | P/E ratio 2022 |
-1.73
x | Employees | 104 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -2.11% | ||
| 1 week | -3.88% | ||
| Current month | -12.26% | ||
| 1 month | -16.59% | ||
| 3 months | -39.27% | ||
| 6 months | +148.83% | ||
| Current year | +148.83% |
1 week
7.38
7.64
1 month
7.048.88
Current year
3.1316.35
1 year
2.8916.35
3 years
2.8943.00
5 years
1.0543.00
10 years
1.0543.00
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel Kruse
CEO | Chief Executive Officer | - | 20/08/23 |
Rebecca Kruse
DFI | Director of Finance/CFO | - | 31/12/22 |
Thomas Haffner
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frank Otto
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/06/24 | 7.44 | -2.11% | 130 |
| 20/06/24 | 7.6 | -1.81% | 130 |
| 19/06/24 | 7.74 | -5.15% | 130 |
| 18/06/24 | 8.16 | -1.69% | 130 |
End-of-day quote BOERSE DUESSELDORF, June 20, 2024
More quotes
SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +148.83% | 37.19M | |
| +1.81% | 3.04B | |
| +97.81% | 1.85B | |
| +96.83% | 66.48M | |
| +277.27% | 52.09M |
- Stock Market
- Equities
- SBX Stock
